RNA virus error catastrophe: Direct molecular test by using ribavirin
暂无分享,去创建一个
C. Cameron | R. Andino | S. Crotty | C E Cameron | S Crotty | R Andino
[1] J. Hoefs,et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.
[2] E. Domingo,et al. Virus mutation frequencies can be greatly underestimated by monoclonal antibody neutralization of virions , 1989, Journal of virology.
[3] J. Arnold,et al. Poliovirus RNA-dependent RNA Polymerase (3Dpol) , 2000, The Journal of Biological Chemistry.
[4] V. Knight,et al. Biochemistry and clinical applications of ribavirin , 1986, Antimicrobial Agents and Chemotherapy.
[5] P. Palese,et al. Antigenic variants of influenza viruses: marked differences in the frequencies of variants selected with different monoclonal antibodies. , 1980, Virology.
[6] C. Pringle. Genetic Characteristics of Conditional Lethal Mutants of Vesicular Stomatitis Virus Induced by 5-Fluorouracil, 5-Azacytidine, and Ethyl Methane Sulfonate , 1970, Journal of virology.
[7] J. B. Antczak,et al. Studies on the mechanism of the antiviral activity of ribavirin against reovirus. , 1989, Virology.
[8] C. Schmaljohn,et al. Antibody-selected variation and reversion in Sindbis virus neutralization epitopes , 1986, Journal of virology.
[9] E. Domingo,et al. Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus , 1997, Journal of virology.
[10] A. Cann,et al. Location and primary structure of a major antigenic site for poliovirus neutralization , 1983, Nature.
[11] J. Arnold,et al. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen , 2000, Nature Medicine.
[12] E. Domingo,et al. Viruses at the edge of adaptation. , 2000, Virology.
[13] E. Pfefferkorn,et al. Isolation and characterization of conditional-lethal mutants of Sindbis virus. , 1966, Virology.
[14] B. Sherry,et al. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14 , 1986, Journal of virology.
[15] P. Wyde. Respiratory syncytial virus (RSV) disease and prospects for its control. , 1998, Antiviral research.
[16] V. Knight,et al. Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis. , 1985, Antiviral research.
[17] E. Domingo,et al. RNA virus mutations and fitness for survival. , 1997, Annual review of microbiology.
[18] J. Mullins,et al. Lethal mutagenesis of HIV with mutagenic nucleoside analogs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Drake,et al. Mutation rates among RNA viruses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Holland,et al. RNA virus populations as quasispecies. , 1992, Current topics in microbiology and immunology.
[21] R. Andino,et al. Poliovirus Requires a Precise 5′ End for Efficient Positive-Strand RNA Synthesis , 2000, Journal of Virology.
[22] J. McCormick,et al. Lassa fever. Effective therapy with ribavirin. , 1986, The New England journal of medicine.
[23] G. Belsham,et al. Studies on the infectivity of foot-and-mouth disease virus RNA using microinjection. , 1988, The Journal of general virology.
[24] Stephen S. Morse,et al. The Evolutionary biology of viruses , 1994 .
[25] Charles Weissmann,et al. Nucleotide sequence heterogeneity of an RNA phage population , 1978, Cell.
[26] R. J. Bauer,et al. Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Crainic,et al. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site , 1986, Journal of virology.
[28] J. Holland,et al. High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[29] Katherine Spindler,et al. Rapid evolution of RNA genomes. , 1982, Science.
[30] J. Parvin,et al. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1 , 1986, Journal of virology.
[31] R. K. Robins,et al. THE RELATIONSHIP BETWEEN THE METABOLISM OF RIBAVIRIN AND ITS PROPOSED MECHANISM OF ACTION , 1977, Annals of the New York Academy of Sciences.
[32] V. Knight,et al. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. , 1985, Antiviral research.
[33] R. K. Robins,et al. Antiviral mechanisms of action. , 1980, Annual review of pharmacology and toxicology.
[34] J. Holland,et al. High nucleotide substitution error frequencies in clonal pools of vesicular stomatitis virus , 1989, Journal of virology.
[35] W. Kirkpatrick,et al. Ribavirin, a broad spectrum antiviral agent , 1980 .
[36] R. K. Robins,et al. Broad-Spectrum Antiviral Activity of Virazole: 1-f8- D-Ribofuranosyl- 1,2,4-triazole- 3-carboxamide , 1972, Science.
[37] P. Harvey. The evolutionary biology of viruses: edited by Stephen S. Morse Raven Press, 1994. $87.00 hbk (xi + 353 pages) ISBN 0781701198 , 1994 .
[38] Christopher J. Miller,et al. Mucosal Immunization of Cynomolgus Macaques with Two Serotypes of Live Poliovirus Vectors Expressing Simian Immunodeficiency Virus Antigens: Stimulation of Humoral, Mucosal, and Cellular Immunity , 1999, Journal of Virology.
[39] M. Eigen,et al. The origin of genetic information: viruses as models. , 1993, Gene.
[40] H. Eggers,et al. Coxsackie A9 Virus: Mutation from Drug Dependence to Drug Independence , 1965, Science.
[41] David A. Steinhauer,et al. Mutation Frequencies at Defined Single Codon Sites in Vesicular Stomatitis Virus and Poliovirus Can Be Increased Only Slightly by Chemical Mutagenesis , 1990, Journal of virology.
[42] E. Domingo,et al. Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus , 1990, Journal of virology.
[43] P. Sharp,et al. An inducible mammalian amber suppressor: Propagation of a poliovirus mutant , 1987, Cell.
[44] J. Miller,et al. A set of lacZ mutations in Escherichia coli that allow rapid detection of each of the six base substitutions. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[45] William M. Lee,et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.
[46] Pedro R. Lowenstein,et al. Response of Foot-and-Mouth Disease Virus to Increased Mutagenesis: Influence of Viral Load and Fitness in Loss of Infectivity , 2000, Journal of Virology.